Replies to post #42553 on RespireRx Pharmaceuticals Inc (RSPI)

[price_and_volume]

Are you suggesting Shareholders won't approve R/S?

Recent filings including the White Lion S-1 indicate RSPI has entered a new round of much-needed 'financing'. I'm not a fan of WL as I've seen their workings in many stocks.

How will shareholders vote? Who holds majority of shares?

As of close of business on September 30, 2020, there were 577,842,003 shares of Common Stock issued and outstanding as compared to 307,430,693 shares issued and outstanding as of August 17, 2020, as reported on the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2020. The increase of 270,411,310 shares issued and outstanding resulted from the conversion of all of the outstanding shares of Series H Preferred Stock, inclusive of accrued but unpaid dividends, into 253,774,260 shares of Common Stock, as well as the exercise of outstanding warrants into 16,637,050 shares of Common Stock. An aggregate of 216,100,903 of such newly issued shares of Common Stock were issued to Mr. Jones and the various trusts into which all Series H Preferred Stock received by both Mr. Margolis and Dr. Lippa were previously transferred.

I tend to agree that anyone who wants 'cheaper shares' may get that opportunity tomorrow.

GLTA